SWX:PSPN
SWX:PSPNReal Estate

PSP Swiss Property's Mixed Earnings Might Change The Case For Investing In PSP Swiss Property (SWX:PSPN)

PSP Swiss Property AG recently reported its third quarter and nine-month 2025 financial results, with quarterly sales reaching CHF 87.48 million and nine-month net income at CHF 259.48 million. While quarterly net income declined compared to the prior year, nine-month net income increased, highlighting continued stability in sales and resilience in overall earnings performance. We'll explore how PSP Swiss Property's rising nine-month net income may influence the company's earnings outlook...
SWX:OERL
SWX:OERLMachinery

Leadership Changes and Barmag Sale Might Change the Case for Investing in OC Oerlikon (SWX:OERL)

OC Oerlikon Management AG recently announced that Marco Freidl will take over as Chief Financial Officer and Dr. Andreas Weiss will join the Executive Committee as General Counsel, following the expected divestment of Barmag to Rieter in late 2025. The appointments introduce finance and legal leaders with deep company experience and capital markets backgrounds, reflecting OC Oerlikon's ongoing transformation and increased focus on core surface solutions. We'll examine how the addition of an...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo Pharmaceuticals (SWX:COPN): Evaluating Valuation as ESG Ratings and Sustainability Milestones Highlight Progress

Cosmo Pharmaceuticals (SWX:COPN) has strengthened its sustainability profile following an upgraded ESG rating from S&P Global as well as a Bronze Medal from EcoVadis for its Italian facility. These developments offer investors an updated lens on the company's governance and environmental integration. See our latest analysis for Cosmo Pharmaceuticals. Momentum has been building behind Cosmo Pharmaceuticals lately, with the share price returning 17.5% over the past three months following the...
SWX:BALN
SWX:BALNInsurance

How Investors May Respond To Baloise Holding (SWX:BALN) Winning Swiss Insurance Innovation Award for AI Concierge

Earlier this month, Baloise was awarded the top prize at the Swiss Insurance Innovation Award for its ‘AI Concierge’ project, which uses generative AI to analyze third-party contracts in real time and create personalized insurance policies for motor vehicle clients. This recognition underscores Baloise’s industry leadership and highlights the company’s ability to deliver tailored, efficient solutions through ongoing digital innovation efforts. We’ll now explore how Baloise’s achievement in...
SWX:GALE
SWX:GALEHealthcare

Galenica (SWX:GALE): Evaluating Valuation After CHF 250 Million Bond Strengthens Balance Sheet

Galenica (SWX:GALE) made headlines by issuing a CHF 250 million fixed rate bond with a 7-year maturity at a 1.08% coupon. This strategic move strengthens long-term financing and repays earlier acquisition-related bridge debt. See our latest analysis for Galenica. The recent bond issuance fits into a year that has seen Galenica focus on stability and longer-term growth, with refinancing efforts building confidence. While the past month’s share price return was a modest negative 2.65%, momentum...
SWX:AMS
SWX:AMSSemiconductor

A Look at ams-OSRAM (SWX:AMS) Valuation After Latest Laser and Automotive Lighting Innovations

ams-OSRAM (SWX:AMS) has rolled out new high-performance laser and LED technologies, including a 5-junction edge-emitting laser for lidar and the PLPM7 Vegalas laser for projection. These advancements bolster its leadership in automotive lighting. See our latest analysis for ams-OSRAM. ams-OSRAM’s recent rollout of advanced laser and LED technologies came at a time when momentum in its stock price has been noticeable. After a standout year-to-date share price return of 66.8%, the past month...
SWX:ALC
SWX:ALCMedical Equipment

Assessing Alcon’s Valuation After Healthcare Sector Rally and Recent Share Price Jump

Ever wondered if Alcon is a hidden gem that is flying under the radar, or if its stock price already reflects all the upside? You are not alone, and this article aims to clear things up. Alcon’s shares have gained 7.1% over the past week and 9.3% in the past month. However, they are still down 16.1% year-to-date and 16.8% over the last year. Recent news has highlighted renewed interest in the broader healthcare sector as investors look for stability amidst global market...
SWX:CLN
SWX:CLNChemicals

Does Clariant's (SWX:CLN) Cautious 2025 Outlook Reflect a Shift in Its Margin Story?

Clariant AG recently confirmed its earnings guidance for 2025, forecasting local currency sales growth at the lower end of its previously outlined 1% to 3% range. This guidance update signals a degree of caution regarding near-term market conditions and could influence how investors view the company's immediate growth prospects. We’ll look at how Clariant’s updated sales outlook may affect confidence in its margin-focused investment narrative. The end of cancer? These 29 emerging AI stocks...
SWX:UBSG
SWX:UBSGCapital Markets

UBS Group’s Debt Buyback Could Be a Game Changer for UBS Group (SWX:UBSG)

UBS Group AG recently completed an upsized multi-billion dollar debt tender offer, increasing its maximum purchase consideration from US$4 billion to US$8.6 billion and accepting US$7.67 billion in principal across several note series for buyback. This large-scale reduction of outstanding debt is an important move aimed at optimizing UBS's capital structure and potentially lowering future interest expenses. We'll explore how UBS Group’s sizeable debt buyback could influence its investment...
SWX:SCMN
SWX:SCMNTelecom

How Investors Are Reacting To Swisscom (SWX:SCMN) Reporting Soaring Revenue and Falling Profitability

On November 5, 2025, Swisscom AG released earnings results for the nine months ended September 30, 2025, reporting sales of CHF 11.18 billion, up from CHF 8.16 billion the previous year. While revenue grew significantly, Swisscom's net income and basic earnings per share both declined from the prior period, reflecting mixed operational trends. With earnings showing increased top-line growth but lower profitability, we explore how these results impact Swisscom's broader investment...
SWX:STMN
SWX:STMNMedical Equipment

Straumann Holding (SWX:STMN) Valuation in Focus Following Smartee Denti-Technology Partnership Announcement

Straumann Holding (SWX:STMN) shares have been in focus after the company revealed a new strategic partnership with Smartee Denti-Technology. This collaboration will combine Straumann’s global dental reach and Smartee’s technical expertise to accelerate innovation in clear aligners. See our latest analysis for Straumann Holding. Straumann Holding’s share price has jumped sharply following its strategic alliance with Smartee Denti-Technology, recording an 18.5% share price return over the past...
SWX:AVOL
SWX:AVOLSpecialty Retail

JFK Luxury Retail Expansion Might Change The Case For Investing In Avolta (SWX:AVOL)

Earlier this year, Avolta announced a series of major new retail contracts and developments at JFK Airport’s Terminal 8, including a mix of luxury global boutiques, a pre-loved luxury shop, and stores echoing New York City’s character, in partnership with Dufry, HMSHost, Hudson, Unibail-Rodamco-Westfield Airports, American Airlines, and the Port Authority of New York and New Jersey. This initiative is part of a US$125 million redevelopment within a wider US$19 billion transformation of JFK...
SWX:SENS
SWX:SENSElectronic

How Sensirion’s New High-Tech Facility and Product Launch Could Shape SWX:SENS Investor Sentiment

Sensirion recently held a groundbreaking ceremony for a new 11,000 m² high-tech production facility in Stafa, Switzerland, designed to address capacity constraints and support future advances in cleanroom manufacturing for the semiconductor industry. By also launching the versatile SGM5304 gas meter module and securing additional land for offices, the company is showcasing both long-term operational commitment and innovation in smart metering solutions to meet the evolving needs of global...
SWX:BANB
SWX:BANBLife Sciences

What Bachem Holding (SWX:BANB)'s Incoming CEO Means for Its Long-Term Leadership Transition

Bachem Holding AG announced that Anne-Kathrin Stoller will become its new CEO on January 1, 2026, following the departure of Thomas Meier after over three decades with the company. Stoller's extensive experience across multiple leadership roles at Bachem, including her recent tenure as Chief Operating Officer Americas, positions her as a leader with deep company and industry knowledge. With Stoller set to bring her operational expertise to the CEO position, we'll explore how this leadership...
SWX:BAER
SWX:BAERCapital Markets

Could Julius Bär (SWX:BAER) Lisbon Expansion Reveal a New Competitive Edge in European Private Banking?

Julius Bär Gruppe recently received regulatory approval to open a dedicated branch of Bank Julius Baer Europe Ltd. in Lisbon, Portugal, with the new office set to begin serving ultra-high and high-net-worth clients in early 2026. This move underscores Julius Bär's ongoing commitment to expanding its European footprint and supporting clients with an established, locally-based team while maintaining leadership continuity. We'll explore how establishing a regulated presence in Lisbon could...
SWX:GALD
SWX:GALDPharmaceuticals

Galderma (SWX:GALD) Valuation in Focus Following FDA Nod for Expanded Restylane Lyft Use

Galderma Group (SWX:GALD) received FDA approval for Restylane Lyft with Lidocaine, now cleared for chin augmentation in adults. Backed by pivotal trial data, this move further broadens Restylane Lyft’s indications in the US market. See our latest analysis for Galderma Group. Galderma Group’s FDA win added fresh momentum to its already impressive run this year. Recent gains have kept investor attention squarely on the company’s growth story. The stock’s 47.6% year-to-date share price return...
SWX:TEMN
SWX:TEMNSoftware

Temenos (SWX:TEMN): Evaluating Valuation After Recent Share Price Momentum

Temenos (SWX:TEMN) has drawn fresh attention after a shift in its recent stock movement. Investors are closely watching how the company’s performance metrics and market sentiment could shape its outlook in the coming months. See our latest analysis for Temenos. Temenos has seen renewed momentum lately, with the share price climbing 14% over the past month and posting a 15% year-to-date gain. While its one-year total shareholder return stands at an impressive 27%, it is still working to...